InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
-1.1%
Across 23 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by ABERNATHY ROBERT E, Director. Insider active across 3 companies, notably AVIENT CORP. In total, 25 filings have been logged. History available since 30 June 2021. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations25 total
1,049 sharesCommon StockSEC:0001122976-26-000108:0
1,055 shares0Common StockSEC:0001127602-25-011090:0
955 shares0Common StockSEC:0001127602-25-000357:0
775 shares0Common StockSEC:0001127602-24-024873:0
2,207 sharesCommon StockSEC:0001127602-24-021040:0
806 shares0Common StockSEC:0001127602-24-019519:0
808 shares0Common StockSEC:0001127602-24-011555:0
834 shares0Common StockSEC:0001127602-24-000239:0
984 shares0Common StockSEC:0001127602-23-025145:0
2,226 sharesCommon StockSEC:0001127602-23-022197:0
863 shares0Common StockSEC:0001127602-23-019842:0
857 shares0Common StockSEC:0001127602-23-011889:0
1,040 shares0Common StockSEC:0001127602-23-000091:0
1,139 shares0Common StockSEC:0001127602-22-023172:0
2,730 sharesCommon StockSEC:0001127602-22-020695:0
880 shares0Common StockSEC:0001127602-22-018403:0
717 shares0Common StockSEC:0001127602-22-011164:0
627 shares0Common StockSEC:0001127602-22-000041
627 shares0Common StockSEC:0001127602-22-000041:0
744 shares0Common StockSEC:0001127602-21-026279:0
744 shares0Common StockSEC:0001127602-21-026279
3,077 sharesCommon StockSEC:0001127602-21-023389
3,077 sharesCommon StockSEC:0001127602-21-023389:0
669 shares0Common StockSEC:0001127602-21-020887
669 shares0Common StockSEC:0001127602-21-020887:0
25 of 25 declarations
About ABERNATHY ROBERT E
Abernathy Robert E serves as a Director at Avient Corp and Haemonetics Corp. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the materials sector allows him to make significant contributions to board discussions. He is committed to supporting the growth and innovation objectives of the companies.
